Alpine Immune Sciences, Inc.
METHODS AND USES OF VARIANT CD80 FUSION PROTEINS AND RELATED CONSTRUCTS

Last updated:

Abstract:

Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of oncological conditions. Compositions and methods for making and using such proteins are provided.

Status:
Application
Type:

Utility

Filling date:

19 Sep 2019

Issue date:

9 Jun 2022